← Leaderboards
Xuchen Aimee Duan
Othro Therapeutics, Inc.
$256,486
Attributed
$256,486
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $128.2K · FY2021–22$200K$150K$100K$50K$0
'21
'22
Funding mix
By agency
NIH$256,486 · 1
By mechanism
R43$256,486 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Alendronate”
- Oyebimpe Oluyemisi Adesina · University Of California At Davis$925,439
- Ryan Dee Ross · Rush University Medical Center$403,164
- Thomas Levin Geiser Andersen · University Of Michigan At Ann Arbor$403,164
- Vilmali Lopez-Mejias · University Of Puerto Rico Rio Piedras$223,500
Research focus
AlendronateAnimal ModelAnimalsArthralgiaArthropathiesArticular CartilageAttenuatedAxonBiological ProcessBisphosphonateBoneBone MarrowBone MatrixBone PainBone RemodelingBone ResorptionBone StructureCaringCartilageCartilage DegradationCellsCharacteristicsClinicAffinity